Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Experienced users with documented tolerance may start at the standard tier
This makes it a common reference point in research comparing systemic versus localized growth factor delivery, and it is one reason IGF-1 LR3 shows up so frequently alongside mechano growth factor in muscle physiology literature
Amgen's MariTide Phase 2 showed no weight loss plateau at 52 weeks (Nov 2024): The absence of a weight loss plateau effect which both semaglutide and tirzepatide display would be a clinically meaningful differentiation if confirmed in Phase 3, potentially enabling greater sustained weight loss
The blend is supplied strictly for research use and is not for human consumption, therapeutic use or medical application
US$ 23.09
US$ 20.74
US$ 22.52
US$ 24.87
